Eight years after joining the Solve ME/CFS Initiative (SMCI), Suzanne D. Vernon, PhD, will be stepping down as Scientific Director in late June. She will continue with the organization in a consultancy role. SMCI has begun an international search for a Research Director. Read More…
Solve ME/CFS Initiative Hosts IOM Briefing in D.C.
On March 25, the Solve ME/CFS Initiative hosted a briefing in Washington, D.C., on the IOM report on ME/CFS [SEID]. The briefing gathered congressional representatives, reporters, government officials and researchers while more than 300 viewed the event through a live webcast. The landmark report was reviewed and Carol Head made a strong and compelling call for more federal research funding. Read More…
$500,000 grant awarded to the Solve ME/CFS Initiative to further epigenetic research
We are thrilled to announce that the Dr. Ralph & Marian Falk Medical Research Trust has awarded $500,000 to the Solve ME/CFS Initiative to further our epigenetic research. READ MORE…
Research Digest – December 2014: 10 Important Advances in ME/CFS
While progress is still far too slow, there have been many recent interesting and important discoveries in ME/CFS. In this year-end blog post, Dr. Vernon and Dr. Komaroff summarize what they regard as the most important recent advances in our field. READ MORE…
Deciphering Post-Exertional Malaise
On September 18, 2014, Dane B. Cook, Ph.D., Associate Professor of Kinesiology at the University of Wisconsin, Madison and a Solve ME/CFS Initiative 2011 funded investigator, presented our most popular webinar of the year on the system biology approach his team is taking to provide a clear picture as to what causes post-exertional malaise. In this guest post for our blog, Dr. Cook reviews the material presented and tackles the many questions we received from webinar participants.
The Importance of a Representative Patient Population for Research
Being able to offer researchers access to ME/CFS patients with demographic and clinical characteristics that represent the full range of people affected with ME/CFS removes a significant hurdle all researchers face. With the SolveCFS BioBank™ we can make ME/CFS research more appealing and accessible. But how do we ensure our SolveCFS BioBank™ is representative of the entire patient population? READ MORE….
Same Mission | New Name
As of Friday, May 30th, The CFIDS Association of America will have a new name – Solve ME/CFS Initiative (SMCI). While our name is changing, our mission steadfastly remains the same: We will make ME/CFS understood, diagnosable and treatable…
CFIDS Association Announces New CEO
The CFIDS Association of America is thrilled to announce the appointment of its new President and CEO, Ms. Carol Head.